Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

AstraZeneca PLC (AZN)

London
Currency in GBP
Disclaimer
10,678.0
-64.0(-0.60%)
Closed

AZN Price Commentary

HiI  am from UK,which broker offer astraz to trade on mt4 ? please tell me if someone have the information. thanks
Proving yet again that it’s the perfect covid play
Earnings above or below forecast what you think?
It has beat it
Does anyone know why this share keep falling?
Broader market conditions are affecting good stocks. But this should rise now towards the earnings, and beyond. The 3 month prospect is extremely good as they’re in front with the vaccine and many other treatments for cancer. The future looks v good for this company - this is a bargain price.
Covi-19 Vaccine data not good. Look like there behind the rest.
Are you joking Marcus? Hahaha! 😂
 Why is its share dropping if the results are good?
This share is still much higher than it was at the beginning of the year. The price was pushed up by short term speculator looking to make a quick profit from the vaccine news. They have sold out for now. However really there is little short term profit from a vaccine AZ will sell at cost apart from good publicity. The real value in this company I think is for long term investors as they have a very good pipline of drugs which will be producing high profits over the next few years.
Good news work against the share price nowadays it seems
15k within 3 months
Why is this share dropping after releasing good trial results?
Simple day traders who do not appreciate the significance of the results .
taking profits from selling , it will bounce back soon
so why are you following it as closely? Commenting.This will be trading at 15k before year end.
can someone explain why the big drop?
Buy on rumor sell on news
Astra Zeneca 🤲
partnership with Deep Matter Ltd. 👍
Source?
go long target 110+
timeframe?
which platform good for shares buying for dividend?
The oxford vaccine failed on Monkeys. Not much in UK Press. but https://indianexpress.com/article/coronavirus/covid-19-vaccine-latest-updates-6419189/ so surprised at AZN announcement.
Can Moderna collaborate with AZN on Covid19 vaccine
They own part of it so yes
bad
What's a good price to buy AZN today, I'm thinking the markets are going to drop the rest the week?
Uniphar Group PLC this pharma provider has better growth i'll say!
Taking into account the sterling slump following Brexit, it is now optimal time for foreign predators to consider the takeover of Astrazeneca cheaply.
Taking into account the sterling slump following Brexit, it is now optimal time for foreign predators to consider the takeover of Astrazeneca cheaply.
Shareholders most likely will now accept the previously rejected offer by Pfizer in usd terms. The same offer represents a 20% improvement in value for shareholders in sterling terms.
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.